表纸
市场调查报告书

多重诊断的全球市场:2020年~2024年

Multiplexed Diagnostics Market by End-user and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品编码 315306
出版日期 内容资讯 英文 120 Pages
订单完成后即时交付
价格
Back to Top
多重诊断的全球市场:2020年~2024年 Multiplexed Diagnostics Market by End-user and Geography - Forecast and Analysis 2020-2024
出版日期: 2020年02月07日内容资讯: 英文 120 Pages
简介

全球多重诊断市场在2020年~2024年的预测期间内,预计将以15%的年复合成长率增长,达到93亿5,000万美元的规模。慢性疾病及感染疾病的流行等促进了市场的成长。此外,技术进步有望推动市场增长。

本报告提供全球多重诊断市场相关调查分析,提供市场规模及成长率,市场趋势,推动市场要素,课题,市场机会验证,再加上主要供应商等相关的系统性资讯。

目录

第1章 摘要整理

第2章 市场的状况

  • 市场生态系统
  • 市场特征

第3章 市场规模

  • 市场定义
  • 市场区隔分析
  • 市场规模(2019年)
  • 市场展望:预测(2019年~2024年)

第4章 波特的五力分析

  • 波特五力分析摘要
  • 买主谈判力
  • 供应商谈判力
  • 新加入厂商的威胁
  • 替代品的威胁
  • 对手的威胁
  • 市场情况

第5章 市场区隔:各终端用户

  • 市场区隔
  • 比较:各终端用户的配置
  • 制药·生物科技企业-市场规模与预测2019-2024
  • 医疗保健中心-市场规模与预测2019年-2024
  • 学术机构和CRO-市场规模与预测2019-2024
  • 市场机会:各终端用户

第6章 客户形势

  • 概要

第7章 各地区形势

  • 各地区市场区隔
  • 各地区比较
  • 北美-市场规模与预测2019-2024
  • 欧洲-市场规模与预测2019-2024
  • 亚太地区-市场规模与预测2019-2024
  • 南美-市场规模与预测2019-2024
  • 中东·非洲地区-市场规模与预测2019-2024
  • 主要国家
  • 市场机会:各地理学

第8章 成长要素,课题,及趋势

  • 数量的成长要素-需求主导型成长
  • 数量的成长要素-外部要素
  • 市场课题
  • 市场趋势

第9章 供应商的展望

  • 业者情势
  • 形势的创新

第10章 供应商分析

  • 交易厂商
  • 供应商的市场定位
  • Agilent Technologies Inc.
  • Becton, Dickinson and Co.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

第11章 附录

  • 调查范围
  • 美金的货币换算比率
  • 调查方法
  • 简称的清单

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: IRTNTR40652

Technavio has been monitoring the global multiplexed diagnostics market and it is poised to grow by USD 9.35 bn during 2020-2024, progressing at a CAGR of 15% during the forecast period. Our reports on global multiplexed diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by prevalence of chronic and infectious diseases.

In addition, technological advancements is anticipated to boost the growth of the global multiplexed diagnostics market as well.

Market Segmentation

Technavio's global multiplexed diagnostics market is segmented as below:

end-user

  • pharmaceutical and biotechnology companies
  • healthcare centers
  • academic institutes and CROs

Geographic segmentation

  • APAC
  • Europe
  • MEA
  • North America
  • South America

Key Trends for global multiplexed diagnostics market growth

This study identifies technological advancements as the prime reasons driving the global multiplexed diagnostics market growth during the next few years.

Prominent vendors in global multiplexed diagnostics market

We provide a detailed analysis of around 25 vendors operating in the global multiplexed diagnostics market, including some of the vendors such as Agilent Technologies Inc., Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, QIAGEN NV, F. Hoffmann-La Roche Ltd., Siemens AG and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user placement
  • Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024
  • Healthcare centers - Market size and forecast 2019-2024
  • Academic institutes and CROs - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • Becton, Dickinson and Co.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.End user placement - Market share 2019-2024 (%)
  • 23.Comparison by End user placement
  • 24.Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ million)
  • 25.Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2024 (%)
  • 26.Healthcare centers - Market size and forecast 2019-2024 ($ million)
  • 27.Healthcare centers - Year-over-year growth 2019-2024 (%)
  • 28.Academic institutes and CROs - Market size and forecast 2019-2024 ($ million)
  • 29.Academic institutes and CROs - Year-over-year growth 2019-2024 (%)
  • 30. Market opportunity by End user
  • 31.Customer landscape
  • 32.Market share by geography 2019-2024 (%)
  • 33.Geographic comparison
  • 34.North America - Market size and forecast 2019-2024 ($ million)
  • 35.North America - Year-over-year growth 2019-2024 (%)
  • 36.Europe - Market size and forecast 2019-2024 ($ million)
  • 37.Europe - Year-over-year growth 2019-2024 (%)
  • 38.APAC - Market size and forecast 2019-2024 ($ million)
  • 39.APAC - Year-over-year growth 2019-2024 (%)
  • 40.South America - Market size and forecast 2019-2024 ($ million)
  • 41.South America - Year-over-year growth 2019-2024 (%)
  • 42.MEA - Market size and forecast 2019-2024 ($ million)
  • 43.MEA - Year-over-year growth 2019-2024 (%)
  • 44.Key leading countries
  • 45.Market opportunity by geography ($ million)
  • 46.Impact of drivers
  • 47.Impact of challenges
  • 48.Landscape disruption
  • 49.Industry risks
  • 50.Vendors covered
  • 51.Market positioning of vendors
  • 52.Agilent Technologies Inc. - Overview (1/3)
  • 53.Agilent Technologies Inc. - Overview (2/3)
  • 54.Agilent Technologies Inc. - Overview (3/3)
  • 55.Agilent Technologies Inc. - Business segments
  • 56.Agilent Technologies Inc. - Key offerings
  • 57.Agilent Technologies Inc. - Key customers
  • 58.Agilent Technologies Inc. - Segment focus
  • 59.Becton, Dickinson and Co. - Overview (1/3)
  • 60.Becton, Dickinson and Co. - Overview (2/3)
  • 61.Becton, Dickinson and Co. - Overview (3/3)
  • 62.Becton, Dickinson and Co. - Business segments
  • 63.Becton, Dickinson and Co. - Key offerings
  • 64.Becton, Dickinson and Co. - Key customers
  • 65.Becton, Dickinson and Co. - Segment focus
  • 66.bioMerieux SA - Overview (1/3)
  • 67.bioMerieux SA - Overview (2/3)
  • 68.bioMerieux SA - Overview (3/3)
  • 69.bioMerieux SA - Business segments
  • 70.bioMerieux SA - Key offerings
  • 71.bioMerieux SA - Key customers
  • 72.bioMerieux SA - Segment focus
  • 73.Bio-Rad Laboratories Inc. - Overview (1/3)
  • 74.Bio-Rad Laboratories Inc. - Overview (2/3)
  • 75.Bio-Rad Laboratories Inc. - Overview (3/3)
  • 76.Bio-Rad Laboratories Inc. - Business segments
  • 77.Bio-Rad Laboratories Inc. - Key offerings
  • 78.Bio-Rad Laboratories Inc. - Key customers
  • 79.Bio-Rad Laboratories Inc. - Segment focus
  • 80.Illumina Inc. - Overview (1/3)
  • 81.Illumina Inc. - Overview (2/3)
  • 82.Illumina Inc. - Overview (3/3)
  • 83.Illumina Inc. - Business segments
  • 84.Illumina Inc. - Key offerings
  • 85.Illumina Inc. - Key customers
  • 86.Illumina Inc. - Segment focus
  • 87.Merck KGaA - Overview (1/3)
  • 88.Merck KGaA - Overview (2/3)
  • 89.Merck KGaA - Overview (3/3)
  • 90.Merck KGaA - Business segments
  • 91.Merck KGaA - Key offerings
  • 92.Merck KGaA - Key customers
  • 93.Merck KGaA - Segment focus
  • 94.QIAGEN NV - Overview (1/3)
  • 95.QIAGEN NV - Overview (2/3)
  • 96.QIAGEN NV - Overview (3/3)
  • 97.QIAGEN NV - Business segments
  • 98.QIAGEN NV - Key offerings
  • 99.QIAGEN NV - Key customers
  • 100.QIAGEN NV - Segment focus
  • 101.F. Hoffmann-La Roche Ltd. - Overview (1/3)
  • 102.F. Hoffmann-La Roche Ltd. - Overview (2/3)
  • 103.F. Hoffmann-La Roche Ltd. - Overview (3/3)
  • 104.F. Hoffmann-La Roche Ltd. - Business segments
  • 105.F. Hoffmann-La Roche Ltd. - Key offerings
  • 106.F. Hoffmann-La Roche Ltd. - Key customers
  • 107.F. Hoffmann-La Roche Ltd. - Segment focus
  • 108.Siemens AG - Overview (1/3)
  • 109.Siemens AG - Overview (2/3)
  • 110.Siemens AG - Overview (3/3)
  • 111.Siemens AG - Business segments
  • 112.Siemens AG - Key offerings
  • 113.Siemens AG - Key customers
  • 114.Siemens AG - Segment focus
  • 115.Thermo Fisher Scientific Inc. - Overview (1/3)
  • 116.Thermo Fisher Scientific Inc. - Overview (2/3)
  • 117.Thermo Fisher Scientific Inc. - Overview (3/3)
  • 118.Thermo Fisher Scientific Inc. - Business segments
  • 119.Thermo Fisher Scientific Inc. - Key offerings
  • 120.Thermo Fisher Scientific Inc. - Key customers
  • 121.Thermo Fisher Scientific Inc. - Segment focus
  • 122.Currency conversion rates for US$
  • 123.Research Methodology
  • 124.Validation techniques employed for market sizing
  • 125.Information sources
  • 126.List of abbreviations
Back to Top